A weak association of HLA-B*2702 with Behcet's disease

被引:52
作者
Gül, A [1 ]
Uyar, FA
Inanç, M
Ocal, L
Barrett, JH
Aral, O
Koniçe, M
Saruhan-Direskeneli, GS
机构
[1] Univ Istanbul, Istanbul Sch Med, Div Rheumatol, Dept Internal Med, TR-34390 Istanbul, Turkey
[2] Univ Istanbul, Istanbul Sch Med, Dept Physiol, TR-34390 Istanbul, Turkey
[3] Univ Manchester, ARC Epidemiol Unit, Manchester, Lancs, England
关键词
Behcet's disease; HLA-B*2702; HLA-B51; immunoglobulin-like killer inhibitory receptor (KIR); NK cell; relative predispositional effects; allelic association;
D O I
10.1038/sj.gene.6363863
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
This study aimed to analyse the association of HLA-B alleles other than -B51 with Behcet's disease (BD), We also investigated the frequency of HLA-B alleles sharing the same natural killer cell immunoglobulin-like receptor (KIR) binding sequence with HLA-B51. Broad-genotyping of HLA-B locus by PCR-SSOP in 174 Turkish BD patients and 191 healthy controls confirmed the strong association of B*51 with BD (60.9% in BD patients, 24.6% in healthy controls, OR=4.78). No other HLA-B allele was identified showing an association with BD after adjusting for multiple testing or by using relative predispositional effects (RPE) analysis after the deletion of B*51. HLA-B alleles reacting with the sequence specific oligonucleotide probe 23, which corresponds to the KIR binding site of B*51, were found to be positive in 127 BD patients (73%) and 90 controls (47%) (OR=3.03, 95% Cl 2-4.7). The repeated RPE analysis after separating HLA-B alleles carrying B51-KIR binding sequence as distinct alleles within a broad-type allele group revealed B*2702 allele as the only allele showing an association with BD after the deletion of B*51. Selective Increase of B*2702, the only B*27 allele carrying the same KIR binding sequence with B*51, warrants investigation of the possibility of interaction of HLA molecules with KIRs on NK or other T cells in the pathogenesis of BD.
引用
收藏
页码:368 / 372
页数:5
相关论文
共 40 条
[1]   SEROLOGICAL AND MOLECULAR HLA TYPING IN ITALIAN BEHCET PATIENTS - SIGNIFICANT ASSOCIATION TO B51-DR5-DQW3 HAPLOTYPE [J].
BALBONI, A ;
PIVETTIPEZZI, P ;
ORLANDO, P ;
RUBINI, M ;
SELVATICI, R ;
ACCORINTI, M ;
BARICORDI, OR ;
GANDINI, E .
TISSUE ANTIGENS, 1992, 39 (03) :141-143
[2]  
BUELOW R, 1995, TRANSPLANTATION, V59, P455
[3]   NK3-SPECIFIC NATURAL-KILLER-CELLS ARE SELECTIVELY INHIBITED BY BW4-POSITIVE HLA ALLELES WITH ISOLEUCINE-80 [J].
CELLA, M ;
LONGO, A ;
FERRARA, GB ;
STROMINGER, JL ;
COLONNA, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1235-1242
[4]   LOCUS-SPECIFIC AMPLIFICATION OF HLA CLASS-I GENES FROM GENOMIC DNA - LOCUS-SPECIFIC SEQUENCES IN THE FIRST AND 3RD INTRONS OF HLA-A, HLA-B, AND HLA-C ALLELES [J].
CEREB, N ;
MAYE, P ;
LEE, S ;
KONG, Y ;
YANG, SY .
TISSUE ANTIGENS, 1995, 45 (01) :1-11
[5]   HLA-B51 MAY SERVE AS AN IMMUNOGENETIC MARKER FOR A SUBGROUP OF PATIENTS WITH BEHCETS-SYNDROME [J].
CHAJEKSHAUL, T ;
PISANTY, S ;
KNOBLER, H ;
MATZNER, Y ;
GLICK, M ;
RON, N ;
ROSENMAN, E ;
BRAUTBAR, C .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (04) :666-672
[6]   Decreased cytotoxic activity of natural killer cells in kidney allograft recipients treated with human HLA-derived peptide [J].
Giral, M ;
Cuturi, MC ;
Nguyen, JM ;
Josien, R ;
Dantal, J ;
Floch, R ;
Buelow, R ;
Pouletty, P ;
Soulillou, JP .
TRANSPLANTATION, 1997, 63 (07) :1004-1011
[7]   HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis [J].
GonzalezRoces, S ;
Alvarez, MV ;
Gonzalez, S ;
Dieye, A ;
Makni, H ;
Woodfield, DG ;
Housan, L ;
Konenkov, V ;
Abbadi, MC ;
Grunnet, N ;
Coto, E ;
LopezLarrea, C .
TISSUE ANTIGENS, 1997, 49 (02) :116-123
[8]  
Gül A, 2001, CLIN EXP RHEUMATOL, V19, pS6
[9]  
Gumperz JE, 1997, J IMMUNOL, V158, P5237
[10]  
HAMZAOUI K, 1990, CLIN EXP IMMUNOL, V79, P28